Creative Medical Technology Holdings files Patent on Induction of Infectious Tolerance by Ex Vivo Reprogrammed Immune Cells Utilizing ImmCelz® Cellular Immunotherapy
- Thursday, December 10, 2020, 8:03
- PR Newswire
- Add a comment
PHOENIX, Dec. 10, 2020 /PRNewswire/ — Creative Medical Technology Holdings trading under the ticker symbol CELZ announced today its patent filing based on data covering utilization of the Company’s ImmCelz® product at generating what is termed in the field of immunology as “infectious…
About the Author
admin has written 20655 stories on this site.